This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Long, J.
Right arrow Articles by Riew, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Long, J.
Right arrow Articles by Riew, K. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 84:1763-1768 (2002)
© 2002 The Journal of Bone and Joint Surgery, Inc.


Scientific Article

The Effect of Cyclooxygenase-2 Inhibitors on Spinal Fusion

John Long, DVM, Stephen Lewis, MD, Timothy Kuklo, MD, Yong Zhu, MD and K. Daniel Riew, MD

Investigation performed at the Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University, St. Louis, Missouri

John Long, DVM
Stephen Lewis, MD
Timothy Kuklo, MD
Yong Zhu, MD
K. Daniel Riew, MD
Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University, One Barnes-Jewish Hospital Plaza, West Pavilion, Suite 11300, St. Louis, MO 63110. E-mail address for K.D. Riew: riewd{at}msnotes.wustl.edu

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Spine surgeons discourage the use of nonsteroidal anti-inflammatory drugs following spine arthrodesis because of their inhibitory effect on bone-healing. To our knowledge, there are no data on the effects of the new cyclooxygenase-2 inhibitors on bone-healing. We undertook this study to determine the effects of these more selective nonsteroidal anti-inflammatory drugs on spinal fusion in a rabbit model.

Methods: Seventy-two New Zealand White rabbits underwent a posterolateral intertransverse process arthrodesis with use of autologous iliac crest bone. Sixty-six rabbits survived the surgical procedure and the perioperative period and had an uneventful postoperative course. These rabbits were randomly divided into three groups. One group received 10 mg/kg of celecoxib orally, the second group received 10 mg/kg of indomethacin orally, and the third group (the control group) received 1 cm 3 of saline solution orally. The rabbits received the treatment daily for eight weeks, after which they were killed and the lumbar spine was harvested. The specimens were palpated for motion, radiographed, and prepared for histological analysis. The quality of the fusion was graded at each level by assigning a histological score of 0 to 7.

Results: Gross inspection and palpation revealed that 64% (fourteen) of the twenty-two control spines and 45% (ten) of the twenty-two spines in the rabbits treated with celecoxib were fused. With the numbers available, this difference was not significant (p = 0.224). Of the twenty-two spines in the indomethacin-treated rabbits, 18% (four) were fused, and this percentage was significantly different from the control value (p = 0.002). On radiographic assessment, the spine segment was deemed to be fused in 82% (eighteen) of the twenty-two controls, 86% (nineteen) of the twenty-two rabbits treated with celecoxib, and 41% (nine) of the twenty-two indomethacin-treated animals. Only the difference between the indomethacin-treated and control groups was significant (p = 0.004). The histological scores averaged 5.2, 4.8, and 3.5 for the control, celecoxib, and indomethacin groups, respectively. There was a significant difference between the control and indomethacin groups (p = 0.002) but not between the celecoxib and control groups (p = 0.161).

Conclusions: These results suggest that celecoxib does not significantly inhibit the rate of spinal fusion in rabbits. They also suggest that the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone-healing are likely mediated by inhibition of cyclooxygenase-1 and that celecoxib is the better choice if treatment with nonsteroidal anti-inflammatory drugs is deemed necessary following spinal arthrodesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko
The Effects of Medications on Bone
J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. Murnaghan, G. Li, and D. R. Marsh
Nonsteroidal Anti-Inflammatory Drug-Induced Fracture Nonunion: An Inhibition of Angiogenesis?
J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
D. B. Cohen, S. Kawamura, J. R. Ehteshami, and S. A. Rodeo
Indomethacin and Celecoxib Impair Rotator Cuff Tendon-to-Bone Healing
Am. J. Sports Med., March 1, 2006; 34(3): 362 - 369.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
S. S. Reuben, D. Ablett, and R. Kaye
High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion: [De fortes doses d'anti-inflammatoires non steroidiens compromettent l'arthrodese vertebrale]
Can J Anesth, May 1, 2005; 52(5): 506 - 512.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. S. Reuben and E. F. Ekman
The Effect of Cyclooxygenase-2 Inhibition on Analgesia and Spinal Fusion
J. Bone Joint Surg. Am., March 1, 2005; 87(3): 536 - 542.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
K. M. Brown, M. M. Saunders, T. Kirsch, H. J. Donahue, and J. S. Reid
Effect of COX-2-Specific Inhibition on Fracture-Healing in the Rat Femur
J. Bone Joint Surg. Am., January 1, 2004; 86(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
P. A. Cole
What's New in Orthopaedic Trauma
J. Bone Joint Surg. Am., November 1, 2003; 85(11): 2260 - 2269.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
N. M. Gajraj
Cyclooxygenase-2 Inhibitors
Anesth. Analg., June 1, 2003; 96(6): 1720 - 1738.
[Full Text] [PDF]

Letters to the Editor:

Read all Letters to the Editor

COX-2 inhibitor may affect bone healing
Benjamin A Goldberg, et al.
JBJS Online, 14 Nov 2002 [Full text]
Re: COX-2 inhibitor may affect bone healing
K. Daniel Riew, et al.
JBJS Online, 19 Nov 2002 [Full text]
Cox-2 response to letter by Drs. Little and Bransford
K. Daniel Riew
JBJS Online, 9 Jun 2003 [Full text]
Untitled
David G. Little
JBJS Online, 8 Oct 2003 [Full text]